{
  "kind": "all",
  "value": "all",
  "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations",
  "filters": {
    "documentKinds": [],
    "sourceTypes": [],
    "orientations": []
  },
  "total": 319975,
  "page": 7494,
  "pageSize": 30,
  "pageCount": 10666,
  "rows": [
    {
      "docId": "019de076-91e2-76fd-b3d2-f30dde172711",
      "docSlug": "0239a71f9c69421092604a0a694fdb09",
      "documentTitle": "AstraZeneca | Investor Conference Presentation Deck | 26 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 12,
      "slideType": "key_messages",
      "function": "size_opportunity",
      "notes": "NME stands for New Molecular Entity. FDC stands for Fixed-Dose Combination.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-91e2-76fd-b3d2-f30dde172711/12",
      "deckHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711",
      "deckAnchorHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711#slide-12",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 14,
          "from": 7,
          "beatId": "aadac6c5-85ff-4c00-8a67-6ccfa3236c41",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Rising Success",
          "beatSlug": "rags-to-riches-rising-success",
          "evidence": "The deck showcases AstraZeneca's successes in various disease areas, including oncology and rare disease.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Development",
          "parentBeatSlug": "development"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-91e2-76fd-b3d2-f30dde172711",
      "docSlug": "0239a71f9c69421092604a0a694fdb09",
      "documentTitle": "AstraZeneca | Investor Conference Presentation Deck | 26 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 13,
      "slideType": "key_messages",
      "function": "summarize",
      "notes": "Includes clinical development pipeline visualization and market growth projections.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-91e2-76fd-b3d2-f30dde172711/13",
      "deckHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711",
      "deckAnchorHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711#slide-13",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 14,
          "from": 7,
          "beatId": "aadac6c5-85ff-4c00-8a67-6ccfa3236c41",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Rising Success",
          "beatSlug": "rags-to-riches-rising-success",
          "evidence": "The deck showcases AstraZeneca's successes in various disease areas, including oncology and rare disease.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Development",
          "parentBeatSlug": "development"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-91e2-76fd-b3d2-f30dde172711",
      "docSlug": "0239a71f9c69421092604a0a694fdb09",
      "documentTitle": "AstraZeneca | Investor Conference Presentation Deck | 26 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 14,
      "slideType": "key_messages",
      "function": "quantify_opportunity",
      "notes": "Includes a table comparing hospitalization rates for RSV, hMPV, and Influenza across age groups.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-91e2-76fd-b3d2-f30dde172711/14",
      "deckHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711",
      "deckAnchorHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711#slide-14",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 14,
          "from": 7,
          "beatId": "aadac6c5-85ff-4c00-8a67-6ccfa3236c41",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Rising Success",
          "beatSlug": "rags-to-riches-rising-success",
          "evidence": "The deck showcases AstraZeneca's successes in various disease areas, including oncology and rare disease.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Development",
          "parentBeatSlug": "development"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-91e2-76fd-b3d2-f30dde172711",
      "docSlug": "0239a71f9c69421092604a0a694fdb09",
      "documentTitle": "AstraZeneca | Investor Conference Presentation Deck | 26 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 15,
      "slideType": "section_divider",
      "function": "transition",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-91e2-76fd-b3d2-f30dde172711/15",
      "deckHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711",
      "deckAnchorHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711#slide-15",
      "loopMatches": [
        {
          "to": 17,
          "from": 15,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "328d8b39-68a9-4a4f-8944-dc6948d92940",
          "evidence": "The deck highlights the potential benefits of AstraZeneca's pipeline and growth strategy.",
          "position": 1,
          "objective": "The cost of not investing in AstraZeneca's pipeline and growth strategy",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.6,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 17,
          "from": 15,
          "beatId": "f8397b24-3413-4fd3-a720-393bac88f957",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "The Breakthrough",
          "beatSlug": "rags-to-riches-the-breakthrough",
          "evidence": "The deck highlights AstraZeneca's pipeline momentum and growth potential.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-91e2-76fd-b3d2-f30dde172711",
      "docSlug": "0239a71f9c69421092604a0a694fdb09",
      "documentTitle": "AstraZeneca | Investor Conference Presentation Deck | 26 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 16,
      "slideType": "key_takeaways",
      "function": "size_opportunity",
      "notes": "The slide uses a waterfall-style growth diagram for Ultomiris and a combination of bar charts and bulleted metrics for HPP assets.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-91e2-76fd-b3d2-f30dde172711/16",
      "deckHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711",
      "deckAnchorHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711#slide-16",
      "loopMatches": [
        {
          "to": 17,
          "from": 15,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "328d8b39-68a9-4a4f-8944-dc6948d92940",
          "evidence": "The deck highlights the potential benefits of AstraZeneca's pipeline and growth strategy.",
          "position": 1,
          "objective": "The cost of not investing in AstraZeneca's pipeline and growth strategy",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.6,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 17,
          "from": 15,
          "beatId": "f8397b24-3413-4fd3-a720-393bac88f957",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "The Breakthrough",
          "beatSlug": "rags-to-riches-the-breakthrough",
          "evidence": "The deck highlights AstraZeneca's pipeline momentum and growth potential.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-91e2-76fd-b3d2-f30dde172711",
      "docSlug": "0239a71f9c69421092604a0a694fdb09",
      "documentTitle": "AstraZeneca | Investor Conference Presentation Deck | 26 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 17,
      "slideType": "key_messages",
      "function": "present_solution",
      "notes": "The slide uses a split layout: left side details specific drug assets (anselamimab, ALXN2220) with clinical stage data, right side outlines the genomic medicine strategy.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-91e2-76fd-b3d2-f30dde172711/17",
      "deckHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711",
      "deckAnchorHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711#slide-17",
      "loopMatches": [
        {
          "to": 17,
          "from": 15,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "328d8b39-68a9-4a4f-8944-dc6948d92940",
          "evidence": "The deck highlights the potential benefits of AstraZeneca's pipeline and growth strategy.",
          "position": 1,
          "objective": "The cost of not investing in AstraZeneca's pipeline and growth strategy",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.6,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 17,
          "from": 15,
          "beatId": "f8397b24-3413-4fd3-a720-393bac88f957",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "The Breakthrough",
          "beatSlug": "rags-to-riches-the-breakthrough",
          "evidence": "The deck highlights AstraZeneca's pipeline momentum and growth potential.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-91e2-76fd-b3d2-f30dde172711",
      "docSlug": "0239a71f9c69421092604a0a694fdb09",
      "documentTitle": "AstraZeneca | Investor Conference Presentation Deck | 26 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 18,
      "slideType": "closing_ask",
      "function": "state_next_steps",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-91e2-76fd-b3d2-f30dde172711/18",
      "deckHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711",
      "deckAnchorHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711#slide-18",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 21,
          "from": 18,
          "beatId": "3cef57b3-4ceb-43aa-be90-d631b3225e75",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Ultimate Achievement",
          "beatSlug": "rags-to-riches-ultimate-achievement",
          "evidence": "The deck concludes with a strong call to action, emphasizing AstraZeneca's unique investment opportunity.",
          "position": 4,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-91e2-76fd-b3d2-f30dde172711",
      "docSlug": "0239a71f9c69421092604a0a694fdb09",
      "documentTitle": "AstraZeneca | Investor Conference Presentation Deck | 26 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 19,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "The slide highlights both internal R&D focus areas and external acquisitions (Cellectis, Quell, Gracell) to support long-term growth.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-91e2-76fd-b3d2-f30dde172711/19",
      "deckHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711",
      "deckAnchorHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711#slide-19",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 21,
          "from": 18,
          "beatId": "3cef57b3-4ceb-43aa-be90-d631b3225e75",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Ultimate Achievement",
          "beatSlug": "rags-to-riches-ultimate-achievement",
          "evidence": "The deck concludes with a strong call to action, emphasizing AstraZeneca's unique investment opportunity.",
          "position": 4,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-91e2-76fd-b3d2-f30dde172711",
      "docSlug": "0239a71f9c69421092604a0a694fdb09",
      "documentTitle": "AstraZeneca | Investor Conference Presentation Deck | 26 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 20,
      "slideType": "key_messages",
      "function": "summarize",
      "notes": "Includes specific targets for 2025, 2026, and 2030.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-91e2-76fd-b3d2-f30dde172711/20",
      "deckHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711",
      "deckAnchorHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711#slide-20",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 21,
          "from": 18,
          "beatId": "3cef57b3-4ceb-43aa-be90-d631b3225e75",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Ultimate Achievement",
          "beatSlug": "rags-to-riches-ultimate-achievement",
          "evidence": "The deck concludes with a strong call to action, emphasizing AstraZeneca's unique investment opportunity.",
          "position": 4,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-91e2-76fd-b3d2-f30dde172711",
      "docSlug": "0239a71f9c69421092604a0a694fdb09",
      "documentTitle": "AstraZeneca | Investor Conference Presentation Deck | 26 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 21,
      "slideType": "key_takeaways",
      "function": "summarize",
      "notes": "The slide uses a four-column layout to highlight key strategic pillars.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-91e2-76fd-b3d2-f30dde172711/21",
      "deckHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711",
      "deckAnchorHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711#slide-21",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 21,
          "from": 18,
          "beatId": "3cef57b3-4ceb-43aa-be90-d631b3225e75",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Ultimate Achievement",
          "beatSlug": "rags-to-riches-ultimate-achievement",
          "evidence": "The deck concludes with a strong call to action, emphasizing AstraZeneca's unique investment opportunity.",
          "position": 4,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-91e2-76fd-b3d2-f30dde172711",
      "docSlug": "0239a71f9c69421092604a0a694fdb09",
      "documentTitle": "AstraZeneca | Investor Conference Presentation Deck | 26 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 22,
      "slideType": "appendix",
      "function": "appendix",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-91e2-76fd-b3d2-f30dde172711/22",
      "deckHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711",
      "deckAnchorHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711#slide-22",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-91e2-76fd-b3d2-f30dde172711",
      "docSlug": "0239a71f9c69421092604a0a694fdb09",
      "documentTitle": "AstraZeneca | Investor Conference Presentation Deck | 26 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 23,
      "slideType": "appendix",
      "function": "appendix",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-91e2-76fd-b3d2-f30dde172711/23",
      "deckHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711",
      "deckAnchorHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711#slide-23",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-91e2-76fd-b3d2-f30dde172711",
      "docSlug": "0239a71f9c69421092604a0a694fdb09",
      "documentTitle": "AstraZeneca | Investor Conference Presentation Deck | 26 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 24,
      "slideType": "appendix",
      "function": "appendix",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-91e2-76fd-b3d2-f30dde172711/24",
      "deckHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711",
      "deckAnchorHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711#slide-24",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-91e2-76fd-b3d2-f30dde172711",
      "docSlug": "0239a71f9c69421092604a0a694fdb09",
      "documentTitle": "AstraZeneca | Investor Conference Presentation Deck | 26 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 25,
      "slideType": "disclaimer",
      "function": "other",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-91e2-76fd-b3d2-f30dde172711/25",
      "deckHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711",
      "deckAnchorHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711#slide-25",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-91e2-76fd-b3d2-f30dde172711",
      "docSlug": "0239a71f9c69421092604a0a694fdb09",
      "documentTitle": "AstraZeneca | Investor Conference Presentation Deck | 26 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 26,
      "slideType": "disclaimer",
      "function": "other",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-91e2-76fd-b3d2-f30dde172711/26",
      "deckHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711",
      "deckAnchorHref": "/decks/019de076-91e2-76fd-b3d2-f30dde172711#slide-26",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-928b-754c-8bda-49c7fed3154d",
      "docSlug": "58a8f830d3c9f9a6fedd64a0d2a10227",
      "documentTitle": "ATAI | Investor Presentation Deck | 34 slides",
      "authorId": "atai",
      "authorName": "atai Life Sciences",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 1,
      "slideType": "cover",
      "function": "front_matter",
      "notes": "Includes company logo, mission statement, and date.",
      "imagePath": "https://imgproxy.kitesheet.com/yzO2ZGhEQi0EWdYpIRGNu9jRYMylI413yuS9PV6auTw/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy81OGE4ZjgzMGQzYzlmOWE2ZmVkZDY0YTBkMmExMDIyNy9wMDAxLmpwZw",
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-928b-754c-8bda-49c7fed3154d/1",
      "deckHref": "/decks/019de076-928b-754c-8bda-49c7fed3154d",
      "deckAnchorHref": "/decks/019de076-928b-754c-8bda-49c7fed3154d#slide-1",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": "https://imgproxy.kitesheet.com/RPzzazLGLu4u9h0S4yXLZIntvCE1wQD_5-QXV6kR1JU/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy81OGE4ZjgzMGQzYzlmOWE2ZmVkZDY0YTBkMmExMDIyNy9wMDAxLnBuZw",
      "thumbSrc": "https://imgproxy.kitesheet.com/h2Pfp9DJax1oQLAnB2mTaXRPMUvSSMM_s_JAz8XuY3o/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy81OGE4ZjgzMGQzYzlmOWE2ZmVkZDY0YTBkMmExMDIyNy9wMDAxLmpwZw",
      "thumbSrcAlt": "https://imgproxy.kitesheet.com/A1cMU5palp2RS3tShRjJGxZ7yVkwMoODRqlbB4so0iA/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy81OGE4ZjgzMGQzYzlmOWE2ZmVkZDY0YTBkMmExMDIyNy9wMDAxLnBuZw"
    },
    {
      "docId": "019de076-928b-754c-8bda-49c7fed3154d",
      "docSlug": "58a8f830d3c9f9a6fedd64a0d2a10227",
      "documentTitle": "ATAI | Investor Presentation Deck | 34 slides",
      "authorId": "atai",
      "authorName": "atai Life Sciences",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 2,
      "slideType": "disclaimer",
      "function": "other",
      "notes": "Page number 02 in top right corner.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-928b-754c-8bda-49c7fed3154d/2",
      "deckHref": "/decks/019de076-928b-754c-8bda-49c7fed3154d",
      "deckAnchorHref": "/decks/019de076-928b-754c-8bda-49c7fed3154d#slide-2",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-928b-754c-8bda-49c7fed3154d",
      "docSlug": "58a8f830d3c9f9a6fedd64a0d2a10227",
      "documentTitle": "ATAI | Investor Presentation Deck | 34 slides",
      "authorId": "atai",
      "authorName": "atai Life Sciences",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 3,
      "slideType": "executive_summary",
      "function": "summarize",
      "notes": "Slide 03 of the deck.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-928b-754c-8bda-49c7fed3154d/3",
      "deckHref": "/decks/019de076-928b-754c-8bda-49c7fed3154d",
      "deckAnchorHref": "/decks/019de076-928b-754c-8bda-49c7fed3154d#slide-3",
      "loopMatches": [
        {
          "to": 34,
          "from": 3,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "c65cfc1b-596e-44b3-abf6-776a6539dcbf",
          "evidence": "The deck emphasizes the need for effective treatments",
          "position": 0,
          "objective": "Highlight the importance of addressing mental health disorders",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.7,
          "description": "Quantify what happens if the audience does nothing"
        },
        {
          "to": 34,
          "from": 3,
          "name": "Golden Circle",
          "slug": "11-golden-circle",
          "bestFor": "Visionary leadership, brand positioning, mission statements",
          "matchId": "7657d45c-02c7-40ab-9afc-a644dc2ed2c5",
          "evidence": "The deck follows a structure that aligns with the Golden Circle",
          "position": 1,
          "objective": "Explain the company's approach and solution",
          "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
          "confidence": 0.7,
          "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 4,
          "from": 3,
          "beatId": "c46ef448-6306-4f67-92f6-ae26d067cb44",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Problem",
          "beatSlug": "sequoia-pitch-problem",
          "evidence": "The executive summary and roadmap slides outline the problem and the company's approach",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-928b-754c-8bda-49c7fed3154d",
      "docSlug": "58a8f830d3c9f9a6fedd64a0d2a10227",
      "documentTitle": "ATAI | Investor Presentation Deck | 34 slides",
      "authorId": "atai",
      "authorName": "atai Life Sciences",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 4,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "The slide uses a Gantt-style visualization to show drug development progress across Preclinical, Phase 1, Phase 2, and Phase 3 stages.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-928b-754c-8bda-49c7fed3154d/4",
      "deckHref": "/decks/019de076-928b-754c-8bda-49c7fed3154d",
      "deckAnchorHref": "/decks/019de076-928b-754c-8bda-49c7fed3154d#slide-4",
      "loopMatches": [
        {
          "to": 34,
          "from": 3,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "c65cfc1b-596e-44b3-abf6-776a6539dcbf",
          "evidence": "The deck emphasizes the need for effective treatments",
          "position": 0,
          "objective": "Highlight the importance of addressing mental health disorders",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.7,
          "description": "Quantify what happens if the audience does nothing"
        },
        {
          "to": 34,
          "from": 3,
          "name": "Golden Circle",
          "slug": "11-golden-circle",
          "bestFor": "Visionary leadership, brand positioning, mission statements",
          "matchId": "7657d45c-02c7-40ab-9afc-a644dc2ed2c5",
          "evidence": "The deck follows a structure that aligns with the Golden Circle",
          "position": 1,
          "objective": "Explain the company's approach and solution",
          "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
          "confidence": 0.7,
          "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 4,
          "from": 3,
          "beatId": "c46ef448-6306-4f67-92f6-ae26d067cb44",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Problem",
          "beatSlug": "sequoia-pitch-problem",
          "evidence": "The executive summary and roadmap slides outline the problem and the company's approach",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        },
        {
          "to": 5,
          "from": 4,
          "beatId": "d35cc5e5-8cdb-4d34-a291-6e8a43f20fd6",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Roadmap",
          "beatSlug": null,
          "evidence": "The roadmap slides outline the expected milestones and timeline",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-928b-754c-8bda-49c7fed3154d",
      "docSlug": "58a8f830d3c9f9a6fedd64a0d2a10227",
      "documentTitle": "ATAI | Investor Presentation Deck | 34 slides",
      "authorId": "atai",
      "authorName": "atai Life Sciences",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 5,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "The slide uses a table-like structure to track progress (checkmarks for completed, squares for upcoming) across 8 distinct drug programs.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-928b-754c-8bda-49c7fed3154d/5",
      "deckHref": "/decks/019de076-928b-754c-8bda-49c7fed3154d",
      "deckAnchorHref": "/decks/019de076-928b-754c-8bda-49c7fed3154d#slide-5",
      "loopMatches": [
        {
          "to": 34,
          "from": 3,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "c65cfc1b-596e-44b3-abf6-776a6539dcbf",
          "evidence": "The deck emphasizes the need for effective treatments",
          "position": 0,
          "objective": "Highlight the importance of addressing mental health disorders",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.7,
          "description": "Quantify what happens if the audience does nothing"
        },
        {
          "to": 34,
          "from": 3,
          "name": "Golden Circle",
          "slug": "11-golden-circle",
          "bestFor": "Visionary leadership, brand positioning, mission statements",
          "matchId": "7657d45c-02c7-40ab-9afc-a644dc2ed2c5",
          "evidence": "The deck follows a structure that aligns with the Golden Circle",
          "position": 1,
          "objective": "Explain the company's approach and solution",
          "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
          "confidence": 0.7,
          "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 16,
          "from": 5,
          "beatId": "09704901-0616-4280-b246-1ed7c74e3475",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Solution",
          "beatSlug": "sequoia-pitch-solution",
          "evidence": "The solution is presented through various product overviews and clinical evidence sections",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        },
        {
          "to": 5,
          "from": 4,
          "beatId": "d35cc5e5-8cdb-4d34-a291-6e8a43f20fd6",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Roadmap",
          "beatSlug": null,
          "evidence": "The roadmap slides outline the expected milestones and timeline",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-928b-754c-8bda-49c7fed3154d",
      "docSlug": "58a8f830d3c9f9a6fedd64a0d2a10227",
      "documentTitle": "ATAI | Investor Presentation Deck | 34 slides",
      "authorId": "atai",
      "authorName": "atai Life Sciences",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 6,
      "slideType": "section_divider",
      "function": "transition",
      "notes": "The slide uses a blue-tinted portrait to evoke a clinical or therapeutic context.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-928b-754c-8bda-49c7fed3154d/6",
      "deckHref": "/decks/019de076-928b-754c-8bda-49c7fed3154d",
      "deckAnchorHref": "/decks/019de076-928b-754c-8bda-49c7fed3154d#slide-6",
      "loopMatches": [
        {
          "to": 34,
          "from": 3,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "c65cfc1b-596e-44b3-abf6-776a6539dcbf",
          "evidence": "The deck emphasizes the need for effective treatments",
          "position": 0,
          "objective": "Highlight the importance of addressing mental health disorders",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.7,
          "description": "Quantify what happens if the audience does nothing"
        },
        {
          "to": 34,
          "from": 3,
          "name": "Golden Circle",
          "slug": "11-golden-circle",
          "bestFor": "Visionary leadership, brand positioning, mission statements",
          "matchId": "7657d45c-02c7-40ab-9afc-a644dc2ed2c5",
          "evidence": "The deck follows a structure that aligns with the Golden Circle",
          "position": 1,
          "objective": "Explain the company's approach and solution",
          "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
          "confidence": 0.7,
          "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 16,
          "from": 5,
          "beatId": "09704901-0616-4280-b246-1ed7c74e3475",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Solution",
          "beatSlug": "sequoia-pitch-solution",
          "evidence": "The solution is presented through various product overviews and clinical evidence sections",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-928b-754c-8bda-49c7fed3154d",
      "docSlug": "58a8f830d3c9f9a6fedd64a0d2a10227",
      "documentTitle": "ATAI | Investor Presentation Deck | 34 slides",
      "authorId": "atai",
      "authorName": "atai Life Sciences",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 7,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Includes two line charts showing PK and PD profiles across different dosage levels.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-928b-754c-8bda-49c7fed3154d/7",
      "deckHref": "/decks/019de076-928b-754c-8bda-49c7fed3154d",
      "deckAnchorHref": "/decks/019de076-928b-754c-8bda-49c7fed3154d#slide-7",
      "loopMatches": [
        {
          "to": 34,
          "from": 3,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "c65cfc1b-596e-44b3-abf6-776a6539dcbf",
          "evidence": "The deck emphasizes the need for effective treatments",
          "position": 0,
          "objective": "Highlight the importance of addressing mental health disorders",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.7,
          "description": "Quantify what happens if the audience does nothing"
        },
        {
          "to": 34,
          "from": 3,
          "name": "Golden Circle",
          "slug": "11-golden-circle",
          "bestFor": "Visionary leadership, brand positioning, mission statements",
          "matchId": "7657d45c-02c7-40ab-9afc-a644dc2ed2c5",
          "evidence": "The deck follows a structure that aligns with the Golden Circle",
          "position": 1,
          "objective": "Explain the company's approach and solution",
          "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
          "confidence": 0.7,
          "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 16,
          "from": 5,
          "beatId": "09704901-0616-4280-b246-1ed7c74e3475",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Solution",
          "beatSlug": "sequoia-pitch-solution",
          "evidence": "The solution is presented through various product overviews and clinical evidence sections",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        },
        {
          "to": 13,
          "from": 7,
          "beatId": "13d3fbaf-8feb-4114-88c3-3adfe518ba85",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Traction",
          "beatSlug": null,
          "evidence": "The traction slides showcase the results from completed studies and clinical evidence",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-928b-754c-8bda-49c7fed3154d",
      "docSlug": "58a8f830d3c9f9a6fedd64a0d2a10227",
      "documentTitle": "ATAI | Investor Presentation Deck | 34 slides",
      "authorId": "atai",
      "authorName": "atai Life Sciences",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 8,
      "slideType": "appendix_methodology",
      "function": "plan_implementation",
      "notes": "The slide outlines a 12-week open-label study with a specific focus on treatment-resistant depression (TRD).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-928b-754c-8bda-49c7fed3154d/8",
      "deckHref": "/decks/019de076-928b-754c-8bda-49c7fed3154d",
      "deckAnchorHref": "/decks/019de076-928b-754c-8bda-49c7fed3154d#slide-8",
      "loopMatches": [
        {
          "to": 34,
          "from": 3,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "c65cfc1b-596e-44b3-abf6-776a6539dcbf",
          "evidence": "The deck emphasizes the need for effective treatments",
          "position": 0,
          "objective": "Highlight the importance of addressing mental health disorders",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.7,
          "description": "Quantify what happens if the audience does nothing"
        },
        {
          "to": 34,
          "from": 3,
          "name": "Golden Circle",
          "slug": "11-golden-circle",
          "bestFor": "Visionary leadership, brand positioning, mission statements",
          "matchId": "7657d45c-02c7-40ab-9afc-a644dc2ed2c5",
          "evidence": "The deck follows a structure that aligns with the Golden Circle",
          "position": 1,
          "objective": "Explain the company's approach and solution",
          "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
          "confidence": 0.7,
          "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 16,
          "from": 5,
          "beatId": "09704901-0616-4280-b246-1ed7c74e3475",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Solution",
          "beatSlug": "sequoia-pitch-solution",
          "evidence": "The solution is presented through various product overviews and clinical evidence sections",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        },
        {
          "to": 13,
          "from": 7,
          "beatId": "13d3fbaf-8feb-4114-88c3-3adfe518ba85",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Traction",
          "beatSlug": null,
          "evidence": "The traction slides showcase the results from completed studies and clinical evidence",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-928b-754c-8bda-49c7fed3154d",
      "docSlug": "58a8f830d3c9f9a6fedd64a0d2a10227",
      "documentTitle": "ATAI | Investor Presentation Deck | 34 slides",
      "authorId": "atai",
      "authorName": "atai Life Sciences",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 9,
      "slideType": "appendix_methodology",
      "function": "plan_implementation",
      "notes": "The slide uses a timeline-based process diagram to illustrate the clinical trial flow.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-928b-754c-8bda-49c7fed3154d/9",
      "deckHref": "/decks/019de076-928b-754c-8bda-49c7fed3154d",
      "deckAnchorHref": "/decks/019de076-928b-754c-8bda-49c7fed3154d#slide-9",
      "loopMatches": [
        {
          "to": 34,
          "from": 3,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "c65cfc1b-596e-44b3-abf6-776a6539dcbf",
          "evidence": "The deck emphasizes the need for effective treatments",
          "position": 0,
          "objective": "Highlight the importance of addressing mental health disorders",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.7,
          "description": "Quantify what happens if the audience does nothing"
        },
        {
          "to": 34,
          "from": 3,
          "name": "Golden Circle",
          "slug": "11-golden-circle",
          "bestFor": "Visionary leadership, brand positioning, mission statements",
          "matchId": "7657d45c-02c7-40ab-9afc-a644dc2ed2c5",
          "evidence": "The deck follows a structure that aligns with the Golden Circle",
          "position": 1,
          "objective": "Explain the company's approach and solution",
          "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
          "confidence": 0.7,
          "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 16,
          "from": 5,
          "beatId": "09704901-0616-4280-b246-1ed7c74e3475",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Solution",
          "beatSlug": "sequoia-pitch-solution",
          "evidence": "The solution is presented through various product overviews and clinical evidence sections",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        },
        {
          "to": 13,
          "from": 7,
          "beatId": "13d3fbaf-8feb-4114-88c3-3adfe518ba85",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Traction",
          "beatSlug": null,
          "evidence": "The traction slides showcase the results from completed studies and clinical evidence",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-928b-754c-8bda-49c7fed3154d",
      "docSlug": "58a8f830d3c9f9a6fedd64a0d2a10227",
      "documentTitle": "ATAI | Investor Presentation Deck | 34 slides",
      "authorId": "atai",
      "authorName": "atai Life Sciences",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 10,
      "slideType": "section_divider",
      "function": "transition",
      "notes": "The slide features a stylized portrait of a person, likely a patient or representative, within a circular frame.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-928b-754c-8bda-49c7fed3154d/10",
      "deckHref": "/decks/019de076-928b-754c-8bda-49c7fed3154d",
      "deckAnchorHref": "/decks/019de076-928b-754c-8bda-49c7fed3154d#slide-10",
      "loopMatches": [
        {
          "to": 34,
          "from": 3,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "c65cfc1b-596e-44b3-abf6-776a6539dcbf",
          "evidence": "The deck emphasizes the need for effective treatments",
          "position": 0,
          "objective": "Highlight the importance of addressing mental health disorders",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.7,
          "description": "Quantify what happens if the audience does nothing"
        },
        {
          "to": 34,
          "from": 3,
          "name": "Golden Circle",
          "slug": "11-golden-circle",
          "bestFor": "Visionary leadership, brand positioning, mission statements",
          "matchId": "7657d45c-02c7-40ab-9afc-a644dc2ed2c5",
          "evidence": "The deck follows a structure that aligns with the Golden Circle",
          "position": 1,
          "objective": "Explain the company's approach and solution",
          "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
          "confidence": 0.7,
          "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 16,
          "from": 5,
          "beatId": "09704901-0616-4280-b246-1ed7c74e3475",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Solution",
          "beatSlug": "sequoia-pitch-solution",
          "evidence": "The solution is presented through various product overviews and clinical evidence sections",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        },
        {
          "to": 13,
          "from": 7,
          "beatId": "13d3fbaf-8feb-4114-88c3-3adfe518ba85",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Traction",
          "beatSlug": null,
          "evidence": "The traction slides showcase the results from completed studies and clinical evidence",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-928b-754c-8bda-49c7fed3154d",
      "docSlug": "58a8f830d3c9f9a6fedd64a0d2a10227",
      "documentTitle": "ATAI | Investor Presentation Deck | 34 slides",
      "authorId": "atai",
      "authorName": "atai Life Sciences",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 11,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "Includes a map of global disease burden and key product features.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-928b-754c-8bda-49c7fed3154d/11",
      "deckHref": "/decks/019de076-928b-754c-8bda-49c7fed3154d",
      "deckAnchorHref": "/decks/019de076-928b-754c-8bda-49c7fed3154d#slide-11",
      "loopMatches": [
        {
          "to": 34,
          "from": 3,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "c65cfc1b-596e-44b3-abf6-776a6539dcbf",
          "evidence": "The deck emphasizes the need for effective treatments",
          "position": 0,
          "objective": "Highlight the importance of addressing mental health disorders",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.7,
          "description": "Quantify what happens if the audience does nothing"
        },
        {
          "to": 34,
          "from": 3,
          "name": "Golden Circle",
          "slug": "11-golden-circle",
          "bestFor": "Visionary leadership, brand positioning, mission statements",
          "matchId": "7657d45c-02c7-40ab-9afc-a644dc2ed2c5",
          "evidence": "The deck follows a structure that aligns with the Golden Circle",
          "position": 1,
          "objective": "Explain the company's approach and solution",
          "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
          "confidence": 0.7,
          "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 16,
          "from": 5,
          "beatId": "09704901-0616-4280-b246-1ed7c74e3475",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Solution",
          "beatSlug": "sequoia-pitch-solution",
          "evidence": "The solution is presented through various product overviews and clinical evidence sections",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        },
        {
          "to": 13,
          "from": 7,
          "beatId": "13d3fbaf-8feb-4114-88c3-3adfe518ba85",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Traction",
          "beatSlug": null,
          "evidence": "The traction slides showcase the results from completed studies and clinical evidence",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-928b-754c-8bda-49c7fed3154d",
      "docSlug": "58a8f830d3c9f9a6fedd64a0d2a10227",
      "documentTitle": "ATAI | Investor Presentation Deck | 34 slides",
      "authorId": "atai",
      "authorName": "atai Life Sciences",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 12,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The slide cites a third-party study (Palhano-Fontes et al.) as proxy evidence for DMT efficacy.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-928b-754c-8bda-49c7fed3154d/12",
      "deckHref": "/decks/019de076-928b-754c-8bda-49c7fed3154d",
      "deckAnchorHref": "/decks/019de076-928b-754c-8bda-49c7fed3154d#slide-12",
      "loopMatches": [
        {
          "to": 34,
          "from": 3,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "c65cfc1b-596e-44b3-abf6-776a6539dcbf",
          "evidence": "The deck emphasizes the need for effective treatments",
          "position": 0,
          "objective": "Highlight the importance of addressing mental health disorders",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.7,
          "description": "Quantify what happens if the audience does nothing"
        },
        {
          "to": 34,
          "from": 3,
          "name": "Golden Circle",
          "slug": "11-golden-circle",
          "bestFor": "Visionary leadership, brand positioning, mission statements",
          "matchId": "7657d45c-02c7-40ab-9afc-a644dc2ed2c5",
          "evidence": "The deck follows a structure that aligns with the Golden Circle",
          "position": 1,
          "objective": "Explain the company's approach and solution",
          "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
          "confidence": 0.7,
          "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 16,
          "from": 5,
          "beatId": "09704901-0616-4280-b246-1ed7c74e3475",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Solution",
          "beatSlug": "sequoia-pitch-solution",
          "evidence": "The solution is presented through various product overviews and clinical evidence sections",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        },
        {
          "to": 13,
          "from": 7,
          "beatId": "13d3fbaf-8feb-4114-88c3-3adfe518ba85",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Traction",
          "beatSlug": null,
          "evidence": "The traction slides showcase the results from completed studies and clinical evidence",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-928b-754c-8bda-49c7fed3154d",
      "docSlug": "58a8f830d3c9f9a6fedd64a0d2a10227",
      "documentTitle": "ATAI | Investor Presentation Deck | 34 slides",
      "authorId": "atai",
      "authorName": "atai Life Sciences",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 13,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The slide uses a process flow diagram to show the progression of the trial parts.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-928b-754c-8bda-49c7fed3154d/13",
      "deckHref": "/decks/019de076-928b-754c-8bda-49c7fed3154d",
      "deckAnchorHref": "/decks/019de076-928b-754c-8bda-49c7fed3154d#slide-13",
      "loopMatches": [
        {
          "to": 34,
          "from": 3,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "c65cfc1b-596e-44b3-abf6-776a6539dcbf",
          "evidence": "The deck emphasizes the need for effective treatments",
          "position": 0,
          "objective": "Highlight the importance of addressing mental health disorders",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.7,
          "description": "Quantify what happens if the audience does nothing"
        },
        {
          "to": 34,
          "from": 3,
          "name": "Golden Circle",
          "slug": "11-golden-circle",
          "bestFor": "Visionary leadership, brand positioning, mission statements",
          "matchId": "7657d45c-02c7-40ab-9afc-a644dc2ed2c5",
          "evidence": "The deck follows a structure that aligns with the Golden Circle",
          "position": 1,
          "objective": "Explain the company's approach and solution",
          "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
          "confidence": 0.7,
          "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 16,
          "from": 5,
          "beatId": "09704901-0616-4280-b246-1ed7c74e3475",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Solution",
          "beatSlug": "sequoia-pitch-solution",
          "evidence": "The solution is presented through various product overviews and clinical evidence sections",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        },
        {
          "to": 13,
          "from": 7,
          "beatId": "13d3fbaf-8feb-4114-88c3-3adfe518ba85",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Traction",
          "beatSlug": null,
          "evidence": "The traction slides showcase the results from completed studies and clinical evidence",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-928b-754c-8bda-49c7fed3154d",
      "docSlug": "58a8f830d3c9f9a6fedd64a0d2a10227",
      "documentTitle": "ATAI | Investor Presentation Deck | 34 slides",
      "authorId": "atai",
      "authorName": "atai Life Sciences",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 14,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a minimalist design with a focus on the product name and target indications, accompanied by a human-centric image.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-928b-754c-8bda-49c7fed3154d/14",
      "deckHref": "/decks/019de076-928b-754c-8bda-49c7fed3154d",
      "deckAnchorHref": "/decks/019de076-928b-754c-8bda-49c7fed3154d#slide-14",
      "loopMatches": [
        {
          "to": 34,
          "from": 3,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "c65cfc1b-596e-44b3-abf6-776a6539dcbf",
          "evidence": "The deck emphasizes the need for effective treatments",
          "position": 0,
          "objective": "Highlight the importance of addressing mental health disorders",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.7,
          "description": "Quantify what happens if the audience does nothing"
        },
        {
          "to": 34,
          "from": 3,
          "name": "Golden Circle",
          "slug": "11-golden-circle",
          "bestFor": "Visionary leadership, brand positioning, mission statements",
          "matchId": "7657d45c-02c7-40ab-9afc-a644dc2ed2c5",
          "evidence": "The deck follows a structure that aligns with the Golden Circle",
          "position": 1,
          "objective": "Explain the company's approach and solution",
          "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
          "confidence": 0.7,
          "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 16,
          "from": 5,
          "beatId": "09704901-0616-4280-b246-1ed7c74e3475",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Solution",
          "beatSlug": "sequoia-pitch-solution",
          "evidence": "The solution is presented through various product overviews and clinical evidence sections",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-928b-754c-8bda-49c7fed3154d",
      "docSlug": "58a8f830d3c9f9a6fedd64a0d2a10227",
      "documentTitle": "ATAI | Investor Presentation Deck | 34 slides",
      "authorId": "atai",
      "authorName": "atai Life Sciences",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 15,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The slide uses a line chart to show the change in MADRS scores over 12 weeks for three different dosages.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-928b-754c-8bda-49c7fed3154d/15",
      "deckHref": "/decks/019de076-928b-754c-8bda-49c7fed3154d",
      "deckAnchorHref": "/decks/019de076-928b-754c-8bda-49c7fed3154d#slide-15",
      "loopMatches": [
        {
          "to": 34,
          "from": 3,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "c65cfc1b-596e-44b3-abf6-776a6539dcbf",
          "evidence": "The deck emphasizes the need for effective treatments",
          "position": 0,
          "objective": "Highlight the importance of addressing mental health disorders",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.7,
          "description": "Quantify what happens if the audience does nothing"
        },
        {
          "to": 34,
          "from": 3,
          "name": "Golden Circle",
          "slug": "11-golden-circle",
          "bestFor": "Visionary leadership, brand positioning, mission statements",
          "matchId": "7657d45c-02c7-40ab-9afc-a644dc2ed2c5",
          "evidence": "The deck follows a structure that aligns with the Golden Circle",
          "position": 1,
          "objective": "Explain the company's approach and solution",
          "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
          "confidence": 0.7,
          "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 16,
          "from": 5,
          "beatId": "09704901-0616-4280-b246-1ed7c74e3475",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Solution",
          "beatSlug": "sequoia-pitch-solution",
          "evidence": "The solution is presented through various product overviews and clinical evidence sections",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    }
  ]
}